Therefore, the purpose of the present study was to evaluate characteristics, survival, and treatment response associated with SMAD4 mutation, and identify characteristics of SMAD4 and TGF-β pathway mutations in CRC cases in The Cancer Genome Atlas (TCGA) database cases. Here, SMAD4 is linked to colorectal carcinoma.